About this trial
The LUNET Registry is intended to serve as a comprehensive primary data source, capturing real-world longitudinal clinical information, and the heterogeneity of patient presentations that are often underrepresented in traditional clinical trials. Ultimately, the LUNET Registry will help to optimize SLE management in routine clinical practice by enabling the compilation of real-world evidence to inform clinical decision-making and health policy. Patients will be enrolled by secondary and tertiary care centres for SLE across Italy in a real-world clinical set-up.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age ≥ 18 years;
confirmed SLE diagnosis according to the SLICC 2012 and/or ACR/EULAR 2019 classification criteria;
provision of signed written informed consent prior to participation
Disqualifiers
None
Trial population
Patients with SLE according to the SLICC 2012 and/or ACR/EULAR 2019 classification criteria
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Remission
Number of patients who achieved complete clinical remission or low disease activity
Disease activity
Changes in disease activity (SLEDAI-2k)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: